The global amnesia therapeutics market has been forecast to grow at a compound annual growth rate (CAGR) of 3.5% over the next eight years, increasing from a market value of £112 million recorded in 2011, to be worth $147 million by 2019.
Growth within the amnesia therapeutics market can be primarily attributed to the increase in the general population and diagnosis rate across the seven major markets (the US, the UK, Japan, Germany, Spain, Italy and France).
Amnesia is a condition in which one's memory is lost. The memory can be either wholly or partially lost due to the extent of damage that was caused.
The global amnesia therapeutics market currently has no approved drugs for the treatment of the condition. Drugs such as benzodiazepines, Selective Serotonin Re-uptake Inhibitors (SSRIs) are commonly prescribed to address symptoms of anxiety and depression in amnesia patients. However, these drugs only focus on improving the patient's quality of life rather than the treatment of amnesia.
Vitamins are an option that should be considered when looking at the treatment of amnesia. Such vitamins are not designed to cure amnesia but, instead, keep the brain organically healthy to improve memory function when short term memory returns.
Vitamin B6 and folic acid are two of the most common vitamins for memory loss. Much like the vitamin supplementation recommended to pregnant women, these two vitamins are crucial to neurological development. In older adults, these two vitamins can assist in keeping the brain healthy during times of illness or when exposed to injury, disease, or other toxins.
For more information on the global amnesia therapeutics market, see the latest research: Global Amnesia Therapeutics Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.